Table 1 Patient and control features.
Patients | Controls | ||
|---|---|---|---|
Without nephritis N = 52 | With nephritis N = 48 | N = 100 | |
Age (mean ± SD) | 43.5 ± 8.4 | 42.5 ± 11.8 | 36.8 ± 11.5 |
Autoantibodies | |||
ANA positive | 79% | 91% | 0% |
Anti dsDNA positive | 28% | 25% | 1% |
Nephritis | 48% | ||
Without biopsy | 47% | ||
Biopsy grade | |||
II | 9% | ||
III | 7% | ||
IV | 36% | ||
V | 2% | ||
Activity (SLEDAI) | |||
Inactive (0–1.99) | 66% | 61% | |
Mild (2–3.99) | 21% | 32% | |
Moderate (4–7.99) | 13% | 5% | |
Severe (more than 8) | 0% | 2% | |
Treatment | |||
Hydroxychloroquine monotherapy | 72% | 42% | |
Hydroxychloroquine in combination | 2% | 22% | |
Others | 4% | 7% | |
Without any treatment | 21% | 29% | |